person

Mikael T.

Country
Sweden
Department
Specialistpsykiatrisk mottagning 2, Norra Stockholms psykiatri, Box 618. SE-113 21 Stockholm

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 4 partner sites.

Specializations

Psychiatric Care

The investigator specializes in the treatment of treatment-resistant depression, with particular focus on developing innovative therapeutic approaches for patients who have not responded adequately to conventional antidepressant treatments.

  • Major Depressive Disorder
  • Treatment Resistance in Depression
  • Antidepressant Augmentation Strategies

This clinical investigator evaluates novel therapeutic compounds for enhancing the effectiveness of standard antidepressant medications.

Pharmacological Interventions

The investigator focuses on combination therapy approaches, specifically examining the potential of adjunctive treatments in conjunction with conventional antidepressants such as SSRIs and SNRIs.

  • Antidepressant Mechanisms
  • Drug Interactions
  • Treatment Optimization

Their work encompasses the evaluation of novel compounds that may enhance the therapeutic effects of existing antidepressant medications.

Mental Health Treatment

The investigator specializes in treatment-resistant psychiatric conditions, with expertise in evaluating the safety and efficacy of experimental therapeutic interventions for patients who have not achieved remission with standard treatments.

  • Clinical Safety Assessment
  • Therapeutic Efficacy
  • Patient Response Evaluation

Their research activities focus on expanding treatment options for patients with difficult-to-treat depression.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.